Shanghai Shen Lian Biomedical Corporation (688098.SS)
CNY 5.89
(0.68%)
CNY 5.89
(0.68%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 301.48 Million | 328.59 Million | 358.42 Million | 337.73 Million | 253.8 Million | 275.13 Million |
| Cost of Revenue | 87.93 Million | 81.39 Million | 86.98 Million | 55.09 Million | 44.95 Million | 54.56 Million |
| Gross Profit | 213.55 Million | 247.19 Million | 271.44 Million | 282.63 Million | 208.85 Million | 220.56 Million |
| Operating Expenses | 177.43 Million | 167.86 Million | 154.95 Million | 153.28 Million | 127.04 Million | 125.24 Million |
| Selling, General and Administrative Expenses | 109.93 Million | 100.81 Million | 91.23 Million | 82.83 Million | 80.17 Million | 80.49 Million |
| Research and Development Expenses | 44.52 Million | 39.03 Million | 34.94 Million | 31.91 Million | 26.56 Million | 21.28 Million |
| Other Expenses | 40.06 Thousand | 28 Million | 28.78 Million | 38.53 Million | 20.3 Million | 372.45 Thousand |
| Cost and Expenses | 265.36 Million | 249.25 Million | 241.94 Million | 208.37 Million | 171.99 Million | 179.81 Million |
| Operating Income | 36.11 Million | 75.23 Million | 128.68 Million | 147.39 Million | 90.85 Million | 100.94 Million |
| Interest Expense | 35.94 Thousand | 12.67 Million | 20.59 Thousand | 27.16 Thousand | 36.82 Thousand | 7324.07 |
| Income Tax Expense | 6.41 Million | 13.57 Million | 21.52 Million | 20.62 Million | 12.88 Million | 13.73 Million |
| Earnings before Tax | 36.26 Million | 74.55 Million | 125.98 Million | 149.99 Million | 90.83 Million | 101.31 Million |
| Net Income | 31.51 Million | 61.1 Million | 110.2 Million | 129.51 Million | 77.95 Million | 87.58 Million |
| Earnings Per Share Basic | 0.08 | 0.15 | 0.27 | 0.32 | 0.19 | 0.26 |
| Earnings Per Share Diluted | 0.08 | 0.15 | 0.27 | 0.31 | 0.19 | 0.26 |
| Weighted Average Shares Outstanding | 393.98 Million | 410.64 Million | 410.64 Million | 409.7 Million | 409.7 Million | 336.84 Million |
| Weighted Average Shares Outstanding (Diluted) | 393.98 Million | 410.64 Million | 410.64 Million | 417.78 Million | 409.7 Million | 336.84 Million |
| Gross Margin | 0.71 | 0.75 | 0.76 | 0.84 | 0.82 | 0.80 |
| EBIT Margin | 0.33 | 0.44 | 0.45 | 0.44 | 0.42 | 0.41 |
| Profit Margin | 0.10 | 0.19 | 0.31 | 0.38 | 0.31 | 0.32 |
| EBITDA | 99.74 Million | 136.4 Million | 169.74 Million | 170.84 Million | 105.81 Million | 113.24 Million |
| Earnings Before Tax Margin | 0.12 | 0.23 | 0.36 | 0.44 | 0.36 | 0.37 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 121.92 Million | 38.31 Million | 88.05 Million | 62.06 Million | 301.48 Million | 116.35 Million |
| Cost of Revenue | 43.97 Million | 18.25 Million | 34.32 Million | 21.14 Million | 87.93 Million | 30.61 Million |
| Gross Profit | 77.95 Million | 20.06 Million | 53.73 Million | 40.91 Million | 213.55 Million | 85.74 Million |
| Operating Expenses | 52.02 Million | 53.17 Million | 55.25 Million | 69.13 Million | 265.36 Million | 52.02 Million |
| Selling, General and Administrative Expenses | 69.7 Million | 23.65 Million | 41.84 Million | 11.03 Million | - | 54.24 Million |
| Research and Development Expenses | 12.13 Million | 12.97 Million | 12.64 Million | 14.26 Million | - | 11.38 Million |
| Other Expenses | -29.81 Million | -263.73 Thousand | -7129.16 | -69.13 Million | -265.36 Million | -337.45 Thousand |
| Cost and Expenses | 95.99 Million | 71.42 Million | 89.57 Million | 69.13 Million | 265.36 Million | 82.63 Million |
| Operating Income | 17.91 Million | -33.38 Million | -3.49 Million | -7.07 Million | 36.11 Million | 32.03 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -1.46 Million | -338.11 Thousand | -377.06 Thousand | -467.37 Thousand | 6.41 Million | 5.14 Million |
| Earnings before Tax | 17.94 Million | -33.64 Million | -3.5 Million | -7.1 Million | 36.26 Million | 31.69 Million |
| Net Income | 20.38 Million | -32.29 Million | -2.2 Million | -5.6 Million | 31.51 Million | 27.19 Million |
| Earnings Per Share Basic | 0.05 | -0.08 | -0.01 | -0.02 | - | 0.07 |
| Earnings Per Share Diluted | 0.05 | -0.08 | -0.01 | -0.02 | - | 0.07 |
| Weighted Average Shares Outstanding | 410.64 Million | 410.64 Million | 338.46 Million | 338.46 Million | 393.98 Million | 410.64 Million |
| Weighted Average Shares Outstanding (Diluted) | 410.64 Million | 410.64 Million | 338.45 Million | 338.45 Million | 393.98 Million | 410.64 Million |
| Gross Margin | 0.64 | 0.52 | 0.61 | 0.66 | 0.71 | 0.74 |
| EBIT Margin | 0.21 | -0.84 | 0.01 | -0.25 | - | 0.31 |
| Profit Margin | 0.17 | -0.84 | -0.03 | -0.09 | 0.10 | 0.23 |
| EBITDA | 25.92 Million | -32.11 Million | 1.13 Million | -15.64 Million | - | 36.5 Million |
| Earnings Before Tax Margin | 0.15 | -0.87 | -0.04 | -0.11 | 0.12 | 0.28 |
IZMO
TGLS
8271
CAV
DFTK
5575